- Release Date: 28/04/20 08:24
- Summary: PXS Cancer Drug Ready to Commence Phase 2 Studies Q4 2020
- Price Sensitive: Yes
- Download Document 145.17KB
- Forums
- ASX - By Stock
- SNT
- Ann: PXS Cancer Drug Ready to Commence Phase 2 Studies Q4 2020
Ann: PXS Cancer Drug Ready to Commence Phase 2 Studies Q4 2020
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.17M |
Open | High | Low | Value | Volume |
3.9¢ | 4.0¢ | 3.7¢ | $66.77K | 1.752M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2713 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 209403 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2713 | 0.038 |
2 | 200997 | 0.037 |
4 | 451544 | 0.036 |
6 | 1278604 | 0.035 |
1 | 200000 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 209403 | 1 |
0.043 | 25000 | 1 |
0.045 | 45224 | 1 |
0.046 | 70076 | 2 |
0.047 | 33889 | 1 |
Last trade - 14.38pm 24/07/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
Previous Video
Next Video
SPONSORED BY The Market Online